N/A
Completed N=37
Ventriculostomies in SAH: ICP Open or Not?
Source: ClinicalTrials.gov NCT00787020 ↗Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Dec 2010
Primary outcomePrimary: Cerebral Artery Vasospasm — 16; 7 Participants
Summary
The purpose of this study is explore how cerebrospinal fluid (CSF) drainage impacts outcomes for patients diagnosed with subarachnoid hemorrhage (SAH). This is a non-randomized observational study of two physician-prescribed approaches to managing intracranial pressure monitoring and CSF drainage for SAH patients. The study will enroll only those patients who have intracranial pressure (ICP) monitoring in situ. Because this is an observational study, there are no physical risks to the patient, the only risk is loss of confidentiality.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cerebral Artery Vasospasm |
16; 7 | — |
| SECONDARY External Ventricular Drain (EVD) Complications |
14; 4 | — |
| SECONDARY Cerebrospinal Fluid (CSF) Output Per Day |
134; 135 | — |
Eligibility Criteria
Inclusion Criteria
- Clinical diagnosis of subarachnoid hemorrhage
- Age 18 years or older
- Ventriculostomy in situ
Exclusion Criteria
- Prisoners
- Glasgow coma score = 3
Data sourced from ClinicalTrials.gov (NCT00787020). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.